BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$58.83
−1.54%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$59.40
From 52W high−13.60%
Volume11.47M
Market cap$120.17B
P/E (TTM)13.0x
P/S (TTM)2.4x
Div yield4.28%
Key dataOct 19, 2026
Open
$59.40
From 52W high
−13.60%
Volume
11.47M
Market cap
$120.17B
ValuationView details →
P/E (Fwd)
9.1x
EV/EBITDA
9.1x
P/E (TTM)
13.0x
RSI (14)
40.7
MomentumView details →
1D Return
−1.54%
YTD Return
+8.84%
SummaryUpdated Jun 1, 2026
Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company founded in 1887 and headquartered in New York. The company was formed through the merger of Bristol-Myers Company and Squibb Corporation, with Bristol-Myers Company tracing its origins to the Clinton Pharmaceutical Company established by William McLaren Bristol and John Ripley Myers. Today, Bristol-Myers Squibb stands as one of the world's leading pharmaceutical companies, focusing on discovering, developing, and commercializing innovative medicines for serious diseases including cancer, cardiovascular conditions, immunological disorders, and neurological conditions.
Similar companies
Latest newsMore news →